Does CANDESARTAN CILEXETIL Cause Second primary malignancy? 6 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Second primary malignancy have been filed in association with CANDESARTAN CILEXETIL (Candesartan). This represents 0.1% of all adverse event reports for CANDESARTAN CILEXETIL.
6
Reports of Second primary malignancy with CANDESARTAN CILEXETIL
0.1%
of all CANDESARTAN CILEXETIL reports
0
Deaths
6
Hospitalizations
How Dangerous Is Second primary malignancy From CANDESARTAN CILEXETIL?
Of the 6 reports, 6 (100.0%) required hospitalization.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CANDESARTAN CILEXETIL. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does CANDESARTAN CILEXETIL Cause?
Headache (706)
Fatigue (705)
Dyspnoea (673)
Drug ineffective (605)
Nausea (605)
Off label use (576)
Acute kidney injury (572)
Dizziness (528)
Malaise (518)
Pain (517)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which CANDESARTAN CILEXETIL Alternatives Have Lower Second primary malignancy Risk?
CANDESARTAN CILEXETIL vs CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE
CANDESARTAN CILEXETIL vs CANGRELOR
CANDESARTAN CILEXETIL vs CANIS LUPUS FAMILIARIS SKIN
CANDESARTAN CILEXETIL vs CANNABIDIOL
CANDESARTAN CILEXETIL vs CANNABIDIOL\HERBALS